The members of the Gene and Disease group aim to utilize comprehensive connectome data obtained in the BRC to delineate the functional map of the
Currently, BRC has pilot projects in cooperation with domestic and international organizations to develop new drugs aimed to enhance the long-term memory of the elderly and patients with brain dysfunction.
Our team includes cross-disciplinary divisions to explore different aspects of learning and memory plus brain function. Core subject includes genetic behaviors (Tsung-Han Kuo, Ann-Shyn Chiang, Josh Dubnau, Chih-Ying Su), cognitive behaviors and disease-related analysis (Ann-Shyn Chiang, Tzu-Kang Sang), automated behavior analysis (Hung-Yin Tsai, Chien-Chung Fu), molecular labeling technology (Tzu-Kang Sang, Ann-Shyn Chiang), disease model establishment and clinical trial cooperation (Ann-Shyn Chiang, Shur-Fen Gau, Chin-Hsien Lin, Ming-Kai Pan, Chia-Wen Chen, Yeon-Ray Wen, Tzu-Kang Sang). The Yushan scholar Tim Tully, the former R & D director of Dart NeuroScience, is in charge of the industrial application and is now working to develop memory-enhancing drugs to treat brain diseases.